A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma

Launched by RENJI HOSPITAL · May 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new method called near-infrared spectroscopy (NIRS) to see if it can accurately detect subcranial hematomas, which are collections of blood that occur under the skull. The goal is to find out how reliable this method is compared to traditional imaging techniques like cranial CT scans. If you or someone you know is over 18 years old and has a confirmed unilateral subcranial hemorrhage (meaning there is bleeding on one side of the brain), you might be eligible to participate in this study.

Participants in this trial will have their hematoma thickness measured using a CT scan as well as undergo NIRS testing. The study is currently recruiting, and anyone interested should be aware that those with bilateral hematomas or certain other conditions, like a significant skull fracture or air in the area of the hemorrhage, will not be included. This research could help improve the way doctors detect and manage brain bleeding in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age above 18 years old
• • 2. Unilateral subcranial hemorrhage confirmed by cranial CT
• Exclusion Criteria:
• • 1. Bilateral subcranial hemorrhage
• • 2. Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT
• • 3. Obvious skull fracture in the location of hemorrhage on cranial CT